Need help finding what you are looking for?
Contact Us
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1629112
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1629112
U.S. and European Union Custom Peptide Synthesis Services Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2030)
PUBLISHED:
PAGES: 252 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The custom peptide synthesis services market in the U.S. is projected to grow from $177.97 million in 2024 to $270.94 million by 2030, registering a compound annual growth rate (CAGR) of 7.8%. In the European Union (EU), the market is expected to expand from $130.76 million in 2024 to $203.51 million by 2030, reflecting a CAGR of 8.2%. This growth is driven by increasing applications of peptides in therapeutic areas, diagnostics, and research. Advances in synthesis technologies, such as automated synthesizers and high-throughput methods, are also contributing to market expansion by improving efficiency and precision.
Key Insights
Peptides are widely used in the development of targeted therapies for diseases such as cancer, infectious diseases, and metabolic disorders, driving demand for custom synthesis services.
Technological advancements, including automated synthesizers and high-throughput production methods, are enabling the synthesis of complex peptides with greater accuracy and scalability.
The growing role of peptides in diagnostic assays for disease detection and monitoring is expanding their application across healthcare settings.
Increasing investments in biotechnology and personalized medicine research are boosting the demand for custom peptide synthesis services in both the U.S. and EU markets.
Stringent quality standards and regulatory requirements in the pharmaceutical industry are leading companies to outsource peptide synthesis to specialized providers to ensure compliance and efficiency.
The market is highly fragmented, with numerous providers focusing on technological innovation and strategic collaborations to strengthen their presence and meet evolving industry needs.
Rising adoption of peptides in vaccine development and therapeutic drug formulations is creating additional growth opportunities for market players.
The strong emphasis on reducing production timelines and costs is driving advancements in peptide synthesis methods, further propelling market growth.
The U.S. remains a dominant market due to its advanced healthcare infrastructure and significant investments in life sciences research, while the EU is experiencing rapid growth due to increasing R&D activities.
Product Code: 13187
Table of Contents
Chapter 1. Research Background
- 1.1 Research Objectives
- 1.2 Market Definition
- 1.3 Analysis Period
- 1.4 Market Data Reporting Unit
- 1.4.1 Value
- 1.5 Market Size Breakdown by Segment
- 1.5.1 Market Segmentation by Purity
- 1.5.2 Market Segmentation by Application
- 1.5.3 Market Segmentation by Technology
- 1.5.4 Market Segmentation by End User
- 1.5.5 Market Segmentation by Geography
- 1.6 Key Stakeholders
Chapter 2. Research Methodology
- 2.1 Secondary Research
- 2.1.1 Paid
- 2.1.2 Unpaid
- 2.1.3 P&S Intelligence Database
- 2.2 Primary Research
- 2.2.1 Breakdown of Primary Research, by Industry Participant
- 2.2.2 Breakdown of Primary Research, by Designation
- 2.2.3 Breakdown of Primary Research, by Company Type
- 2.3 Market Size Estimation
- 2.4 Data Triangulation
- 2.5 Currency Conversion Rates
- 2.6 Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Definition of Market Segments
- 4.1 By Product
- 4.1.1 By Purity
- 4.1.1.1 Up to 75%
- 4.1.1.2 76-90%
- 4.1.1.3 Above 90%
- 4.1.1.1 Up to 75%
- 4.1.2 By Application
- 4.1.2.1 Peptide therapeutics
- 4.1.2.2 Antibody production
- 4.1.2.3 Biomarker discovery
- 4.1.2.4 Isotopic labeling
- 4.1.2.5 Protein production
- 4.1.2.6 Cosmetics development
- 4.1.2.7 Others
- 4.1.3 By Technology
- 4.1.3.1 SPPS
- 4.1.3.2 LPPS
- 4.1.3.3 Hybrid
- 4.1.4 By End User
- 4.1.4.1 Pharmaceutical & biotechnology companies
- 4.1.4.2 Research institutes
- 4.1.4.3 Others
- 4.1.1 By Purity
Chapter 5. Industry Outlook
- 5.1 U.S. Market Dynamics
- 5.1.1 Trends
- 5.1.1.1 Advancements in technology
- 5.1.1.2 Increasing applications in therapeutics and diagnostics
- 5.1.2 Drivers
- 5.1.2.1 Expanding biotechnology and pharmaceutical industries
- 5.1.2.2 Growing demand for personalized medicine
- 5.1.2.3 Increasing focus on cancer and infectious disease research
- 5.1.3 Impact Analysis of Drivers on Market Forecast
- 5.1.4 Restraints
- 5.1.4.1 High cost associated with peptide production
- 5.1.4.2 Technical challenges impacting efficiency and reliability of peptide production
- 5.1.5 Impact Analysis of Restraints on Market Forecast
- 5.1.6 Opportunities
- 5.1.6.1 Development of peptide-based therapeutics
- 5.1.6.2 Expansion into new research areas
- 5.1.1 Trends
- 5.2 EU Market Dynamics
- 5.2.1 Trends
- 5.2.1.1 Growth in research and development activities
- 5.2.1.2 Focus on ensuring high quality and regulatory compliance
- 5.2.2 Drivers
- 5.2.2.1 Strong intellectual property and market protection framework
- 5.2.2.2 High emphasis on sustainability and green practices
- 5.2.2.3 Growing demand for personalized medicine and diagnostics
- 5.2.3 Impact Analysis of Drivers on Market Forecast
- 5.2.4 Restraints
- 5.2.4.1 Supply chain disruptions
- 5.2.4.2 Regulatory and compliance challenges
- 5.2.5 Impact Analysis of Restraints on Market Forecast
- 5.2.6 Opportunities
- 5.2.6.1 Unmet demand in emerging Eastern European markets
- 5.2.1 Trends
- 5.3 Impact of COVID-19
- 5.4 Porter's Five Forces Analysis
- 5.4.1 Bargaining Power of Buyers
- 5.4.2 Bargaining Power of Suppliers
- 5.4.3 Intensity of Rivalry
- 5.4.4 Threat of New Entrants
- 5.4.5 Threat of Substitutes
Chapter 6. U.S. Market Size and Forecast
- 6.1 Overview
- 6.2 Market Revenue, by Purity (2019-2030)
- 6.3 Market Revenue, by Application (2019-2030)
- 6.4 Market Revenue, by Technology (2019-2030)
- 6.5 Market Revenue, by End User (2019-2030)
Chapter 7. EU Market Size and Forecast
- 7.1 Overview
- 7.2 Market Revenue, by Purity (2019-2030)
- 7.3 Market Revenue, by Application (2019-2030)
- 7.4 Market Revenue, by Technology (2019-2030)
- 7.5 Market Revenue, by End User (2019-2030)
- 7.6 Market Revenue, by Country (2019-2030)
Chapter 8. Germany Market Size and Forecast
- 8.1 Overview
- 8.2 Market Revenue, by Purity (2019-2030)
- 8.3 Market Revenue, by Application (2019-2030)
- 8.4 Market Revenue, by Technology (2019-2030)
- 8.5 Market Revenue, by End User (2019-2030)
Chapter 9. France Market Size and Forecast
- 9.1 Overview
- 9.2 Market Revenue, by Purity (2019-2030)
- 9.3 Market Revenue, by Application (2019-2030)
- 9.4 Market Revenue, by Technology (2019-2030)
- 9.5 Market Revenue, by End User (2019-2030)
Chapter 10. Switzerland Market Size and Forecast
- 10.1 Overview
- 10.2 Market Revenue, by Purity (2019-2030)
- 10.3 Market Revenue, by Application (2019-2030)
- 10.4 Market Revenue, by Technology (2019-2030)
- 10.5 Market Revenue, by End User (2019-2030)
Chapter 11. Italy Market Size and Forecast
- 11.1 Overview
- 11.2 Market Revenue, by Purity (2019-2030)
- 11.3 Market Revenue, by Application (2019-2030)
- 11.4 Market Revenue, by Technology (2019-2030)
- 11.5 Market Revenue, by End User (2019-2030)
Chapter 12. Spain Market Size and Forecast
- 12.1 Overview
- 12.2 Market Revenue, by Purity (2019-2030)
- 12.3 Market Revenue, by Application (2019-2030)
- 12.4 Market Revenue, by Technology (2019-2030)
- 12.5 Market Revenue, by End User (2019-2030)
Chapter 13. Belgium Market Size and Forecast
- 13.1 Overview
- 13.2 Market Revenue, by Purity (2019-2030)
- 13.3 Market Revenue, by Application (2019-2030)
- 13.4 Market Revenue, by Technology (2019-2030)
- 13.5 Market Revenue, by End User (2019-2030)
Chapter 14. Netherlands Market Size and Forecast
- 14.1 Overview
- 14.2 Market Revenue, by Purity (2019-2030)
- 14.3 Market Revenue, by Application (2019-2030)
- 14.4 Market Revenue, by Technology (2019-2030)
- 14.5 Market Revenue, by End User (2019-2030)
Chapter 15. Denmark Market Size and Forecast
- 15.1 Overview
- 15.2 Market Revenue, by Purity (2019-2030)
- 15.3 Market Revenue, by Application (2019-2030)
- 15.4 Market Revenue, by Technology (2019-2030)
- 15.5 Market Revenue, by End User (2019-2030)
Chapter 16. Poland Market Size and Forecast
- 16.1 Overview
- 16.2 Market Revenue, by Purity (2019-2030)
- 16.3 Market Revenue, by Application (2019-2030)
- 16.4 Market Revenue, by Technology (2019-2030)
- 16.5 Market Revenue, by End User (2019-2030)
Chapter 17. Sweden Market Size and Forecast
- 17.1 Overview
- 17.2 Market Revenue, by Purity (2019-2030)
- 17.3 Market Revenue, by Application (2019-2030)
- 17.4 Market Revenue, by Technology (2019-2030)
- 17.5 Market Revenue, by End User (2019-2030)
Chapter 18. Austria Market Size and Forecast
- 18.1 Overview
- 18.2 Market Revenue, by Purity (2019-2030)
- 18.3 Market Revenue, by Application (2019-2030)
- 18.4 Market Revenue, by Technology (2019-2030)
- 18.5 Market Revenue, by End User (2019-2030)
Chapter 19. Competitive Landscape
- 19.1 List of Market Players and Their Offerings
- 19.2 Recent Strategic Developments of Key Players
- 19.2.1 Product Launches and Approvals
- 19.2.2 Partnerships and Collaborations
- 19.2.3 Facility Expansion
- 19.2.4 Other Developments
Chapter 20. Company Profiles
- 20.1 GenScript Biotech Corporation
- 20.1.1 Business Overview
- 20.1.2 Product and Service Offerings
- 20.1.3 Key Financial Summary
- 20.2 Intavis Peptide Services GmbH
- 20.2.1 Business Overview
- 20.2.2 Product and Service Offerings
- 20.3 PolyPeptide Group AG
- 20.3.1 Business Overview
- 20.3.2 Product and Service Offerings
- 20.3.3 Key Financial Summary
- 20.4 RS Synthesis
- 20.4.1 Business Overview
- 20.4.2 Product and Service Offerings
- 20.5 21st Century Biochemicals Inc.
- 20.5.1 Business Overview
- 20.5.2 Product and Service Offerings
- 20.6 Advanced ChemTech
- 20.6.1 Business Overview
- 20.6.2 Product and Service Offerings
- 20.7 Peptide 2.0 Inc.
- 20.7.1 Business Overview
- 20.7.2 Product and Service Offerings
- 20.8 BCNPeptides S.A.U.
- 20.8.1 Business Overview
- 20.8.2 Product and Service Offerings
- 20.9 Schafer-N ApS
- 20.9.1 Business Overview
- 20.9.2 Product and Service Offerings
- 20.10 Synbio Technologies
- 20.10.1 Business Overview
- 20.10.2 Product and Service Offerings
- 20.11 AAPPTec LLC
- 20.11.1 Business Overview
- 20.11.2 Product and Service Offerings
- 20.12 Abcepta Inc.
- 20.12.1 Business Overview
- 20.12.2 Product and Service Offerings
- 20.13 Bachem AG
- 20.13.1 Business Overview
- 20.13.2 Product and Service Offerings
- 20.13.3 Key Financial Summary
- 20.14 Merck KGaA
- 20.14.1 Business Overview
- 20.14.2 Product and Service Offerings
- 20.14.3 Key Financial Summary
- 20.15 JPT Peptide Technologies GmbH
- 20.15.1 Business Overview
- 20.15.2 Product and Service Offerings
- 20.16 Biosynth Ltd.
- 20.16.1 Business Overview
- 20.16.2 Product and Service Offerings
- 20.17 Almac Group Limited
- 20.17.1 Business Overview
- 20.17.2 Product and Service Offerings
- 20.18 CSBio
- 20.18.1 Business Overview
- 20.18.2 Product and Service Offerings
- 20.19 Applied Biological USA Materials Inc.
- 20.19.1 Business Overview
- 20.19.2 Product and Service Offerings
- 20.20 Thermo Fisher Scientific Inc.
- 20.20.1 Business Overview
- 20.20.2 Product and Service Offerings
- 20.20.3 Key Financial Summary
- 20.21 BIOSYNTAN GmbH
- 20.21.1 Business Overview
- 20.21.2 Product and Service Offerings
- 20.22 CASLO ApS
- 20.22.1 Business Overview
- 20.22.2 Product and Service Offerings
- 20.23 Covalab Inc.
- 20.23.1 Business Overview
- 20.23.2 Product and Service Offerings
- 20.24 AmbioPharm Inc.
- 20.24.1 Business Overview
- 20.24.2 Product and Service Offerings
- 20.25 Biomatik Corporation
- 20.25.1 Business Overview
- 20.25.2 Product and Service Offerings
- 20.26 AnaSpec
- 20.26.1 Business Overview
- 20.26.2 Product and Service Offerings
- 20.27 Creative Proteomics
- 20.27.1 Business Overview
- 20.27.2 Product and Service Offerings
- 20.28 Elabscience Bionovation Inc.
- 20.28.1 Business Overview
- 20.28.2 Product and Service Offerings
- 20.29 Kaneka Eurogentec S.A.
- 20.29.1 Business Overview
- 20.29.2 Product and Service Offerings
- 20.3 Genosphere Biotechnologies
- 20.30.1 Business Overview
- 20.30.2 Product and Service Offerings
- 20.31 mk2 Biotechnologies GmbH
- 20.31.1 Business Overview
- 20.31.2 Product and Service Offerings
- 20.32 WuXi TIDES
- 20.32.1 Business Overview
- 20.32.2 Product and Service Offerings
- 20.33 Davids Biotechnologie GmbH
- 20.33.1 Business Overview
- 20.33.2 Product and Service Offerings
Chapter 21. Appendix
- 21.1 Sources and References
- 21.2 Related Reports
Product Code: 13187
List of Tables
- TABLE 1 ANALYSIS PERIOD OF THE STUDY
- TABLE 2 Drivers for The u.s. Market: Impact Analysis
- TABLE 3 restraints for The U.S. Market: Impact Analysis
- TABLE 4 Drivers for The EU Market: Impact Analysis
- TABLE 5 restraints for The EU Market: Impact Analysis
- TABLE 6 U.S. custom peptide synthesis services market Revenue, BY purity, $M (2019-2024)
- TABLE 7 U.S. custom peptide synthesis services market Revenue, BY purity, $M (2025-2030)
- TABLE 8 U.S. custom peptide synthesis services market Revenue, BY Application, $M (2019-2024)
- TABLE 9 U.S. custom peptide synthesis services market Revenue, BY Application, $M (2025-2030)
- TABLE 10 U.S. custom peptide synthesis services market Revenue, BY Technology, $M (2019-2024)
- TABLE 11 U.S. custom peptide synthesis services market Revenue, BY Technology, $M (2025-2030)
- TABLE 12 U.S. custom peptide synthesis services market Revenue, BY End User, $M (2019-2024)
- TABLE 13 U.S. custom peptide synthesis services market Revenue, BY End User, $M (2025-2030)
- TABLE 14 EU custom peptide synthesis services market Revenue, BY purity, $M (2019-2024)
- TABLE 15 EU custom peptide synthesis services market Revenue, BY purity, $M (2025-2030)
- TABLE 16 EU custom peptide synthesis services market Revenue, BY Application, $M (2019-2024)
- TABLE 17 EU custom peptide synthesis services market Revenue, BY Application, $M (2025-2030)
- TABLE 18 EU custom peptide synthesis services market Revenue, BY Technology, $M (2019-2024)
- TABLE 19 EU custom peptide synthesis services market Revenue, BY Technology, $M (2025-2030)
- TABLE 20 EU custom peptide synthesis services market Revenue, BY End User, $M (2019-2024)
- TABLE 21 EU custom peptide synthesis services market Revenue, BY End User, $M (2025-2030)
- TABLE 22 EU custom peptide synthesis services market Revenue, BY country, $M (2019-2024)
- TABLE 23 EU custom peptide synthesis services market Revenue, BY country, $M (2025-2030)
- TABLE 24 GERMANY custom peptide synthesis services market Revenue, BY purity, $M (2019-2024)
- TABLE 25 GERMANY custom peptide synthesis services market Revenue, BY purity, $M (2025-2030)
- TABLE 26 GERMANY custom peptide synthesis services market Revenue, BY Application, $M (2019-2024)
- TABLE 27 GERMANY custom peptide synthesis services market Revenue, BY Application, $M (2025-2030)
- TABLE 28 GERMANY custom peptide synthesis services market Revenue, BY Technology, $M (2019-2024)
- TABLE 29 GERMANY custom peptide synthesis services market Revenue, BY Technology, $M (2025-2030)
- TABLE 30 GERMANY custom peptide synthesis services market Revenue, BY End User, $M (2019-2024)
- TABLE 31 GERMANY custom peptide synthesis services market Revenue, BY End User, $M (2025-2030)
- TABLE 32 FRANCE custom peptide synthesis services market Revenue, BY purity, $M (2019-2024)
- TABLE 33 FRANCE custom peptide synthesis services market Revenue, BY purity, $M (2025-2030)
- TABLE 34 FRANCE custom peptide synthesis services market Revenue, BY Application, $M (2019-2024)
- TABLE 35 FRANCE custom peptide synthesis services market Revenue, BY Application, $M (2025-2030)
- TABLE 36 FRANCE custom peptide synthesis services market Revenue, BY Technology, $M (2019-2024)
- TABLE 37 FRANCE custom peptide synthesis services market Revenue, BY Technology, $M (2025-2030)
- TABLE 38 FRANCE custom peptide synthesis services market Revenue, BY End User, $M (2019-2024)
- TABLE 39 FRANCE custom peptide synthesis services market Revenue, BY End User, $M (2025-2030)
- TABLE 40 SWITZERLAND custom peptide synthesis services market Revenue, BY purity, $M (2019-2024)
- TABLE 41 SWITZERLAND custom peptide synthesis services market Revenue, BY purity, $M (2025-2030)
- TABLE 42 SWITZERLAND custom peptide synthesis services market Revenue, BY Application, $M (2019-2024)
- TABLE 43 SWITZERLAND custom peptide synthesis services market Revenue, BY Application, $M (2025-2030)
- TABLE 44 SWITZERLAND custom peptide synthesis services market Revenue, BY Technology, $M (2019-2024)
- TABLE 45 SWITZERLAND custom peptide synthesis services market Revenue, BY Technology, $M (2025-2030)
- TABLE 46 SWITZERLAND custom peptide synthesis services market Revenue, BY End User, $M (2019-2024)
- TABLE 47 SWITZERLAND custom peptide synthesis services market Revenue, BY End User, $M (2025-2030)
- TABLE 48 ITALY custom peptide synthesis services market Revenue, BY purity, $M (2019-2024)
- TABLE 49 ITALY custom peptide synthesis services market Revenue, BY purity, $M (2025-2030)
- TABLE 50 ITALY custom peptide synthesis services market Revenue, BY Application, $M (2019-2024)
- TABLE 51 ITALY custom peptide synthesis services market Revenue, BY Application, $M (2025-2030)
- TABLE 52 ITALY custom peptide synthesis services market Revenue, BY Technology, $M (2019-2024)
- TABLE 53 ITALY custom peptide synthesis services market Revenue, BY Technology, $M (2025-2030)
- TABLE 54 ITALY custom peptide synthesis services market Revenue, BY End User, $M (2019-2024)
- TABLE 55 ITALY custom peptide synthesis services market Revenue, BY End User, $M (2025-2030)
- TABLE 56 SPAIN custom peptide synthesis services market Revenue, BY purity, $M (2019-2024)
- TABLE 57 SPAIN custom peptide synthesis services market Revenue, BY purity, $M (2025-2030)
- TABLE 58 SPAIN custom peptide synthesis services market Revenue, BY Application, $M (2019-2024)
- TABLE 59 SPAIN custom peptide synthesis services market Revenue, BY Application, $M (2025-2030)
- TABLE 60 SPAIN custom peptide synthesis services market Revenue, BY Technology, $M (2019-2024)
- TABLE 61 SPAIN custom peptide synthesis services market Revenue, BY Technology, $M (2025-2030)
- TABLE 62 SPAIN custom peptide synthesis services market Revenue, BY End User, $M (2019-2024)
- TABLE 63 SPAIN custom peptide synthesis services market Revenue, BY End User, $M (2025-2030)
- TABLE 64 BELGIUM custom peptide synthesis services market Revenue, BY purity, $M (2019-2024)
- TABLE 65 BELGIUM custom peptide synthesis services market Revenue, BY purity, $M (2025-2030)
- TABLE 66 BELGIUM custom peptide synthesis services market Revenue, BY Application, $M (2019-2024)
- TABLE 67 BELGIUM custom peptide synthesis services market Revenue, BY Application, $M (2025-2030)
- TABLE 68 BELGIUM custom peptide synthesis services market Revenue, BY Technology, $M (2019-2024)
- TABLE 69 BELGIUM custom peptide synthesis services market Revenue, BY Technology, $M (2025-2030)
- TABLE 70 BELGIUM custom peptide synthesis services market Revenue, BY End User, $M (2019-2024)
- TABLE 71 BELGIUM custom peptide synthesis services market Revenue, BY End User, $M (2025-2030)
- TABLE 72 NETHERLANDS custom peptide synthesis services market Revenue, BY purity, $M (2019-2024)
- TABLE 73 NETHERLANDS custom peptide synthesis services market Revenue, BY purity, $M (2025-2030)
- TABLE 74 NETHERLANDS custom peptide synthesis services market Revenue, BY Application, $M (2019-2024)
- TABLE 75 NETHERLANDS custom peptide synthesis services market Revenue, BY Application, $M (2025-2030)
- TABLE 76 NETHERLANDS custom peptide synthesis services market Revenue, BY Technology, $M (2019-2024)
- TABLE 77 NETHERLANDS custom peptide synthesis services market Revenue, BY Technology, $M (2025-2030)
- TABLE 78 NETHERLANDS custom peptide synthesis services market Revenue, BY End User, $M (2019-2024)
- TABLE 79 NETHERLANDS custom peptide synthesis services market Revenue, BY End User, $M (2025-2030)
- TABLE 80 DENMARK custom peptide synthesis services market Revenue, BY purity, $M (2019-2024)
- TABLE 81 DENMARK custom peptide synthesis services market Revenue, BY purity, $M (2025-2030)
- TABLE 82 DENMARK custom peptide synthesis services market Revenue, BY Application, $M (2019-2024)
- TABLE 83 DENMARK custom peptide synthesis services market Revenue, BY Application, $M (2025-2030)
- TABLE 84 DENMARK custom peptide synthesis services market Revenue, BY Technology, $M (2019-2024)
- TABLE 85 DENMARK custom peptide synthesis services market Revenue, BY Technology, $M (2025-2030)
- TABLE 86 DENMARK custom peptide synthesis services market Revenue, BY End User, $M (2019-2024)
- TABLE 87 DENMARK custom peptide synthesis services market Revenue, BY End User, $M (2025-2030)
- TABLE 88 POLAND custom peptide synthesis services market Revenue, BY purity, $M (2019-2024)
- TABLE 89 POLAND custom peptide synthesis services market Revenue, BY purity, $M (2025-2030)
- TABLE 90 POLAND custom peptide synthesis services market Revenue, BY Application, $M (2019-2024)
- TABLE 91 POLAND custom peptide synthesis services market Revenue, BY Application, $M (2025-2030)
- TABLE 92 POLAND custom peptide synthesis services market Revenue, BY Technology, $M (2019-2024)
- TABLE 93 POLAND custom peptide synthesis services market Revenue, BY Technology, $M (2025-2030)
- TABLE 94 POLAND custom peptide synthesis services market Revenue, BY End User, $M (2019-2024)
- TABLE 95 POLAND custom peptide synthesis services market Revenue, BY End User, $M (2025-2030)
- TABLE 96 SWEDEN custom peptide synthesis services market Revenue, BY purity, $M (2019-2024)
- TABLE 97 SWEDEN custom peptide synthesis services market Revenue, BY purity, $M (2025-2030)
- TABLE 98 SWEDEN custom peptide synthesis services market Revenue, BY Application, $M (2019-2024)
- TABLE 99 SWEDEN custom peptide synthesis services market Revenue, BY Application, $M (2025-2030)
- TABLE 100 SWEDEN custom peptide synthesis services market Revenue, BY Technology, $M (2019-2024)
- TABLE 101 SWEDEN custom peptide synthesis services market Revenue, BY Technology, $M (2025-2030)
- TABLE 102 SWEDEN custom peptide synthesis services market Revenue, BY End User, $M (2019-2024)
- TABLE 103 SWEDEN custom peptide synthesis services market Revenue, BY End User, $M (2025-2030)
- TABLE 104 AUSTRIA custom peptide synthesis services market Revenue, BY purity, $M (2019-2024)
- TABLE 105 AUSTRIA custom peptide synthesis services market Revenue, BY purity, $M (2025-2030)
- TABLE 106 AUSTRIA custom peptide synthesis services market Revenue, BY Application, $M (2019-2024)
- TABLE 107 AUSTRIA custom peptide synthesis services market Revenue, BY Application, $M (2025-2030)
- TABLE 108 AUSTRIA custom peptide synthesis services market Revenue, BY Technology, $M (2019-2024)
- TABLE 109 AUSTRIA custom peptide synthesis services market Revenue, BY Technology, $M (2025-2030)
- TABLE 110 AUSTRIA custom peptide synthesis services market Revenue, BY End User, $M (2019-2024)
- TABLE 111 AUSTRIA custom peptide synthesis services market Revenue, BY End User, $M (2025-2030)
- TABLE 112 List OF PLAYERS and their Offerings
- TABLE 113 Genscript Biotech Corporation - At a glance
- TABLE 114 GENSCRIPT BIOTECH CORPORATION - KEY FINANCIAL summary
- TABLE 116 PolyPeptide Group AG - At a glance
- TABLE 117 PolyPeptide Group AG - key financial summary
- TABLE 118 RS Synthesis - At a glance
- TABLE 119 21st Century Biochemicals Inc. - AT a Glance
- TABLE 120 advanced chemtech - At a Glance
- TABLE 121 Peptide 2.0 Inc. - AT a Glance
- TABLE 122 BCNPeptides S.A.U. - AT a Glance
- TABLE 123 Schafer-N ApS - AT A GLANCE
- TABLE 124 Synbio Technologies - AT A GLANCE
- TABLE 125 AAPPTec LLC - At a Glance
- TABLE 126 Abcepta inc. - at a glance
- TABLE 127 ABCEPTA inc. - cUSTOM PEPTIDE Specifications
- TABLE 128 BACHEM AG - at a glance
- TABLE 129 BACHEM AG - Custom Peptides Specifications
- TABLE 130 Bachem AG - Key financial Summary
- TABLE 131 MERck kgaa - at a glance
- TABLE 132 MERCK KGAA - custom peptide SPECIFICATIONs
- TABLE 133 MERCK KGAA - custom peptide GUIDELINES FOR SELECTING THE PURITY
- TABLE 134 merck kgaa - Key financial Summary
- TABLE 135 JPT Peptide Technologies GmbH - At a Glance
- TABLE 136 JPT Peptide Technologies GmbH - cUSTOM PEPTIDE Specifications
- TABLE 137 Biosynth Ltd. - at a glance
- TABLE 138 Almac Group Limited - at a glance
- TABLE 139 CSBIO - at a glance
- TABLE 140 Applied Biological Materials usa Inc. - At a Glance
- TABLE 141 Applied Biological Materials usa Inc. - cUSTOM PEPTIDE sYNTHESIS SERVICE Price
- TABLE 142 Thermo Fisher Scientific Inc. - at a glance
- TABLE 143 Thermo Fisher Scientific Inc. - cUSTOM PEPTIDE sYNTHESIS services
- TABLE 144 Thermo Fisher Scientific Inc. - Key financial Summary
- TABLE 145 Biosyntan GmbH - At a Glance
- TABLE 146 CASLO ApS - at a glance
- TABLE 147 Covalab Inc. - at a glance
- TABLE 148 AmbioPharm Inc. - At a glance
- TABLE 149 Biomatik CORPORATION - At a glance
- TABLE 150 BIOMATIK CORPORATION - CUSTOM PEPTIDE SPECIFICATIONS
- TABLE 151 AnaSpec - At a glance
- TABLE 152 AnaSpec - CUSTOM PEPTIDE SPECIFICATIONS
- TABLE 153 Creative Proteomics - At a glance
- TABLE 154 Creative Proteomics - custom peptide specifications and modification
- TABLE 155 Elabscience Bionovation Inc. - At a glance
- TABLE 156 Kaneka Eurogentec S.A. - At a glance
- TABLE 157 Genosphere Biotechnologies - At a glance
- TABLE 158 mk2 Biotechnologies GmbH - At a glance
- TABLE 159 WuXi TIDES - At a glance
- TABLE 160 Davids Biotechnologie GmbH - At a glance
- TABLE 161 TABLE 5 Davids Biotechnologie GmbH - CUSTOM PEPTIDE SPECIFICATIONS
List of Figures
- FIG 1 Market Size Breakdown by Segment
- FIG 2 RESEARCH methodology
- FIG 3 breakdown of primary research, by industry participant
- FIG 4 breakdown of primary research, by Designation
- FIG 5 breakdown of primary research, by company type
- FIG 6 data triangulation approach
- FIG 7 Currency Conversion Rates for USD (2023)
- FIG 8 U.S. and EU Custom peptide synthesis Services MARKET SUMMARY
- FIG 9 Bargaining power of buyers
- FIG 10 bargaining power of suppliers
- FIG 11 intensity of rivalry
- FIG 12 threat of new entrants
- FIG 13 Threat of substitutes
- FIG 14 U.S. custom peptide synthesis services market Revenue, BY purity, $M (2019-2030)
- FIG 15 U.S. custom peptide synthesis services market Revenue, BY Application, $M (2019-2030)
- FIG 16 U.S. custom peptide synthesis services market Revenue, BY End User, $M (2019-2030)
- FIG 17 EU custom peptide synthesis services market Revenue, BY purity, $M (2019-2030)
- FIG 18 EU custom peptide synthesis services market Revenue, BY Application, $M (2019-2030)
- FIG 19 EU custom peptide synthesis services market Revenue, BY Technology, $M (2019-2030)
- FIG 20 EU custom peptide synthesis services market Revenue, BY End User, $M (2019-2030)
- FIG 21 EU custom peptide synthesis services market Revenue, BY country, $M (2019-2030)
- FIG 22 GERMANY custom peptide synthesis services market Revenue, BY purity, $M (2019-2030)
- FIG 23 GERMANY custom peptide synthesis services market Revenue, BY Application, $M (2019-2030)
- FIG 24 GERMANY custom peptide synthesis services market Revenue, BY Technology, $M (2019-2030)
- FIG 25 GERMANY custom peptide synthesis services market Revenue, BY End User, $M (2019-2030)
- FIG 26 FRANCE custom peptide synthesis services market Revenue, BY purity, $M (2019-2030)
- FIG 27 FRANCE custom peptide synthesis services market Revenue, BY Application, $M (2019-2030)
- FIG 28 FRANCE custom peptide synthesis services market Revenue, BY Technology, $M (2019-2030)
- FIG 29 FRANCE custom peptide synthesis services market Revenue, BY End User, $M (2019-2030)
- FIG 30 SWITZERLAND custom peptide synthesis services market Revenue, BY purity, $M (2019-2030)
- FIG 31 SWITZERLAND custom peptide synthesis services market Revenue, BY Application, $M (2019-2030)
- FIG 32 SWITZERLAND custom peptide synthesis services market Revenue, BY Technology, $M (2019-2030)
- FIG 33 SWITZERLAND custom peptide synthesis services market Revenue, BY End User, $M (2019-2030)
- FIG 34 ITALY custom peptide synthesis services market Revenue, BY purity, $M (2019-2030)
- FIG 35 ITALY custom peptide synthesis services market Revenue, BY Application, $M (2019-2030)
- FIG 36 ITALY custom peptide synthesis services market Revenue, BY Technology, $M (2019-2030)
- FIG 37 ITALY custom peptide synthesis services market Revenue, BY End User, $M (2019-2030)
- FIG 38 SPAIN custom peptide synthesis services market Revenue, BY purity, $M (2019-2030)
- FIG 39 SPAIN custom peptide synthesis services market Revenue, BY Application, $M (2019-2030)
- FIG 40 SPAIN custom peptide synthesis services market Revenue, BY Technology, $M (2019-2030)
- FIG 41 SPAIN custom peptide synthesis services market Revenue, BY End User, $M (2019-2030)
- FIG 42 BELGIUM custom peptide synthesis services market Revenue, BY purity, $M (2019-2030)
- FIG 43 BELGIUM custom peptide synthesis services market Revenue, BY Application, $M (2019-2030)
- FIG 44 BELGIUM custom peptide synthesis services market Revenue, BY Technology, $M (2019-2030)
- FIG 45 BELGIUM custom peptide synthesis services market Revenue, BY End User, $M (2019-2030)
- FIG 46 NETHERLANDS custom peptide synthesis services market Revenue, BY purity, $M (2019-2030)
- FIG 47 NETHERLANDS custom peptide synthesis services market Revenue, BY Application, $M (2019-2030)
- FIG 48 NETHERLANDS custom peptide synthesis services market Revenue, BY Technology, $M (2019-2030)
- FIG 49 NETHERLANDS custom peptide synthesis services market Revenue, BY End User, $M (2019-2030)
- FIG 50 DENMARK custom peptide synthesis services market Revenue, BY purity, $M (2019-2030)
- FIG 51 DENMARK custom peptide synthesis services market Revenue, BY Application, $M (2019-2030)
- FIG 52 DENMARK custom peptide synthesis services market Revenue, BY Technology, $M (2019-2030)
- FIG 53 DENMARK custom peptide synthesis services market Revenue, BY End User, $M (2019-2030)
- FIG 54 POLAND custom peptide synthesis services market Revenue, BY purity, $M (2019-2030)
- FIG 55 POLAND custom peptide synthesis services market Revenue, BY Application, $M (2019-2030)
- FIG 56 POLAND custom peptide synthesis services market Revenue, BY Technology, $M (2019-2030)
- FIG 57 POLAND custom peptide synthesis services market Revenue, BY End User, $M (2019-2030)
- FIG 58 SWEDEN custom peptide synthesis services market Revenue, BY purity, $M (2019-2030)
- FIG 59 SWEDEN custom peptide synthesis services market Revenue, BY Application, $M (2019-2030)
- FIG 60 SWEDEN custom peptide synthesis services market Revenue, BY Technology, $M (2019-2030)
- FIG 61 SWEDEN custom peptide synthesis services market Revenue, BY End User, $M (2019-2030)
- FIG 62 AUSTRIA custom peptide synthesis services market Revenue, BY purity, $M (2019-2030)
- FIG 63 AUSTRIA custom peptide synthesis services market Revenue, BY Application, $M (2019-2030)
- FIG 64 AUSTRIA custom peptide synthesis services market Revenue, BY Technology, $M (2019-2030)
- FIG 65 AUSTRIA custom peptide synthesis services market Revenue, BY End User, $M (2019-2030)
- FIG 66 Genescript biotech corporation - Revenue split by segment and geography (2023)
- FIG 67 PolyPeptide Group AG - Revenue split by business area, therapEUTIC AREA, CUSTOMER TYPE, and geography (2023)
- FIG 68 bachem AG - Revenue split by segment and geography (2023)
- FIG 69 merck kgaa - Revenue split by segment and geography (2023)
- FIG 70 Thermo Fisher Scientific Inc. - Revenue split by segment and geography (2023)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.